← FDA DRUG APPROVALS

FDA ANDA · ANDA076780

ONDANSETRON

Sponsor: HIKMA FARMACEUTICA

APPLICATION
ANDA076780
TYPE
ANDA
ORIGINAL APPROVAL
2006-12-26
LATEST ACTION
2026-04-08
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREEDiscontinued
ONDANSETRON HYDROCHLORIDE EQ 2MG BASE/ML · INJECTABLE · INJECTION

Approval history

2026-04-08Labeling · Supplement 20 · standardAP
2023-04-26Labeling · Supplement 19 · standardAP
2023-04-26Labeling · Supplement 17 · standardAP
2014-12-20Labeling · Supplement 16 · standardAP
2014-12-20Labeling · Supplement 15 · standardAP
2013-09-19Labeling · Supplement 14 · standardAP
2012-04-30Labeling · Supplement 13AP
2011-01-31Labeling · Supplement 11AP
2006-12-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →